E* Chi'mes at the Alzheimer's Association International Conference (AAIC) 2025 – Toronto.

E* Chi'mes is proud to have taken part in the Alzheimer’s Association International Conference (AAIC) 2025, held in Toronto, Canada—one of the most influential global gatherings for dementia and Alzheimer’s research.

Our presence at this year’s conference allowed us to connect with world-renowned researchers, healthcare professionals, and organizations dedicated to advancing understanding and treatment of Alzheimer’s disease and other neurological conditions.

At the E* Chi'mes booth, we showcased our commitment to brain health through innovative, science-backed solutions—particularly NeuroAiD II, a neurorestorative product, and Tripgard (Amitriptyline), a trusted support for neurological and mental health. These products continue to represent our core advocacy: supporting cognitive health and improving quality of life for patients and caregivers.

We are grateful for the opportunity to share insights, engage in global dialogue, and explore future collaborations that align with our mission. A heartfelt thank you to everyone who visited our booth and shared their passion and expertise with us.]\